Literature DB >> 8011344

Perfusion-related factors of endotoxin release during cardiopulmonary bypass.

P G Jansen1, H Te Velthuis, H M Oudemans-Van Straaten, E R Bulder, S J Van Deventer, A Sturk, L Eijsman, C R Wildevuur.   

Abstract

To investigate whether the release of endotoxin during cardiopulmonary bypass (CPB) is determined by perfusion-related factors, endotoxin concentrations were determined before, during, and after CPB in 21 male patients (age range 45-75 years) undergoing elective coronary artery bypass grafting. Hemodynamic parameters and oncotic pressure were also measured. Significant increases in endotoxin concentrations were observed after the start of CPB (P < 0.005), before aortic cross-clamp release (P < 0.05), and after aortic cross-clamp release (P < 0.05). The median endotoxin concentration after cessation of CPB was 0.264 EU/ml (range < 0.036-0.480 EU/ml). Endotoxin concentrations derived from the prime solutions were not contributory. Positive correlations were found between arterial pressure after the start of CPB and the endotoxin concentration 10 min after (r = 0.58, P < 0.01) and between the duration of aortic cross-clamping and the endotoxin concentration after the cessation of CPB (r = 0.64, P < 0.005). Arterial pressure after the start of CPB, the duration of aortic cross-clamping, and decrease in oncotic pressure appeared to be independent variables in a forward variable selection model that predicted endotoxin concentrations after CPB. We conclude that in patients undergoing elective coronary artery bypass grafting, an early phase of endotoxin release during CPB could be demonstrated, and that this is due to vasoconstriction. The endotoxin concentrations after the cessation of CPB were determined by early vasoconstriction, duration of aortic cross-clamping, and hypo-oncotic hemodilution.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011344     DOI: 10.1016/1010-7940(94)90167-8

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxemia.

Authors:  H M Oudemans-van Straaten; P G Jansen; H te Velthuis; I C Beenakkers; C P Stoutenbeek; S J van Deventer; A Sturk; L Eysman; C R Wildevuur
Journal:  Intensive Care Med       Date:  1996-04       Impact factor: 17.440

2.  Peptidoglycan of Staphylococcus aureus upregulates monocyte expression of CD14, Toll-like receptor 2 (TLR2), and TLR4 in human blood: possible implications for priming of lipopolysaccharide signaling.

Authors:  J S Hadley; J E Wang; S J Foster; C Thiemermann; C J Hinds
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

3.  Prevalence of endotoxemia after surgery and its association with ICU length of stay.

Authors:  Franco Valenza; Lorella Fagnani; Silvia Coppola; Sara Froio; Francesca Sacconi; Cecilia Tedesco; Micol Maffioletti; Marta Pizzocri; Valentina Salice; Maria Luisa Ranzi; Cristina Marenghi; Luciano Gattinoni
Journal:  Crit Care       Date:  2009-06-29       Impact factor: 9.097

4.  Alkaline Phosphatase in Infant Cardiopulmonary Bypass: Kinetics and Relationship to Organ Injury and Major Cardiovascular Events.

Authors:  Jesse A Davidson; Tracy T Urban; Christine Baird; Suhong Tong; Alan Woodruff; Mark Twite; James Jaggers; Eric A F Simões; Paul Wischmeyer
Journal:  J Pediatr       Date:  2017-11       Impact factor: 4.406

5.  Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery: a prospective observational study.

Authors:  David J Klein; Francoise Briet; Rosane Nisenbaum; Alexander D Romaschin; C David Mazer
Journal:  Crit Care       Date:  2011-02-23       Impact factor: 9.097

6.  Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence.

Authors:  John C Marshall; Paul M Walker; Debra M Foster; David Harris; Melanie Ribeiro; Jeff Paice; Alexander D Romaschin; Anastasia N Derzko
Journal:  Crit Care       Date:  2002-05-02       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.